AdaptHealth Corp. , alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States.
Adapthealth stock last closed at $10.80, up 1.12% from the previous day, and has increased 20.4% in one year. It has overperformed other stocks in the Medical Devices industry by 1.2 percentage points. Adapthealth stock is currently +26.98% from its 52-week low of $8.51, and -19.58% from its 52-week high of $13.43.
There are currently 136.05M shares of AHCO outstanding. The market value of AHCO is $1.47B. In the past 24 hours, 718,000 AHCO shares were traded.
How to Buy Adapthealth Stock
Not sure how to invest in Adapthealth stock? Here's how.
Decide where to buy Adapthealth stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Adapthealth stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Put funds into your brokerage account: Pick your payment method and add your information.
Evaluate Adapthealth stock: The Adapthealth ticker symbol is AHCO. Is Adapthealth stock a good investment? Should you buy shares of AHCO? How do AHCO's underlying business fundamentals look? Do top analysts think Adapthealth is a good buy? Why has AHCO's stock price moved recently? (Hint: Our stock market research website can help you evaluate if AHCO is a good stock to buy).
Make your AHCO buy order: Decide if you will purchase AHCO shares at the current market price or use a limit order to purchase AHCO shares at a particular price.
Track your AHCO position: Create a watchlist to important notifications about your position in Adapthealth shares.
Step 1: Decide where to buy Adapthealth stock
You need an online brokerage account to access the NASDAQ market and buy AHCO stock.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal information so you are able to invest in AHCO stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Adapthealth stock
Once you have decided on the best place to buy Adapthealth stock, it's crucial to analyze their stock before you buy, so you can understand the risk as well as the opportunity.
Adapthealth shares quick numbers
AHCO Price
$10.80
1w %
0.37%
1y %
20.4%
5y %
-50.55%
P/E
-18.31x
P/B
0.97x
P/S
0.45x
PEG
N/A
Revenue
$3.29B
Earnings
-$79.63M
Fore. Rev. Growth
6.79%
Fore. Earn. Growth
N/A
Market Cap
$1.47B
Next Earnings
Aug 4, 2026
Next Dividend
N/A
AHCO Due Diligence Score
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
AHCO's operating cash flow of $599.97M allows it to safely service it's debt of $2.00B.
Failed Financial Due Diligence Checks:
There are more long-term liabilities than short-term assets on the AHCO balance sheet.
AHCO profit margin has gone down from 2.6% to -2.4% in the past year.
AHCO earnings of $68.12M is not enough to cover its interest payments.
AHCO has a relatively high debt to equity ratio of 1.93.
Total AHCO debt is higher than 5 years ago, relative to shareholder equity.
There are more short-term liabilities than short-term assets on the AHCO balance sheet.
Is Adapthealth stock a Buy, Hold, or Sell, according to analysts?
Out of 7 Equities analysts who give forecasts on AHCO, the consensus analyst rating on Adapthealth is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent AHCO Analyst Recommendations
David S Macdonald, a top 8% analyst from Truist Securities maintains AHCO with a strong buy rating and raises their AHCO price target from $13.00 to $14.00, on Apr 13, 2026.
Truist Securities's David S Macdonald raised their price target on Adapthealth (NASDAQ: AHCO) by 7.7% from $13 to $14 on 2026/04/13. The analyst maintained their Strong Buy rating on the stock.
Macdonald's price target hike on Adapthealth was part of a pre-print review of names in their Healthcare Services (HC) sector coverage area.
With the latest Final Medicare Advantage Rule viewed as an "encouraging data point," the analyst said they take a generally positive view of group names because of sustained robust demand trends, underlying secular tailwinds, and a more favorable/stable reimbursement backdrop.
Macdonald argued that the sector remains in a good position, citing scalability, its domestic nature, and defensive characteristics.
The analyst pointed out that the group benefits from AI, automation, and connectivity, and that group names have attractive financial flexibility, strong free cash flow, ongoing growth investments, M&A opportunities, and shareholder-friendly initiatives to back them up.
Whit Mayo, a top 22% analyst from Leerink Partners maintains AHCO with a buy rating and lowers their AHCO price target from $13.00 to $12.00, on Feb 26, 2026.
Last year, AHCO revenue was $3.29B. Over the past 5 year, AHCO's revenue has gone up by 19.53% per year. This was faster than the Medical Devices industry average of 9.4%.
Over the last 12 months, insiders at AHCO have bought more shares than they have sold.
Iii Russell E. Schuster, Chief Commercial Officer of AHCO, was the latest AHCO insider to sell. They sold $117,711.00 worth of AHCO stock on Jul 1, 2026.
No, Adapthealth doesn't provide an income stream by paying out dividends.
What do other investors have to say about AHCO?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your AHCO buy order
There are two main order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a particular price limit, use a limit order.
Press the Open button and your broker will place the order.
If you require additional help buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Adapthealth share?
As of Jul 31, 2026, it costs $10.80 to buy one share of Adapthealth stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.463 shares of AHCO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.